Rifapentine and Isoniazid for Latent Tuberculosis

被引：0
|
作者：
Mirsaeidi, Mehdi [1 ]
机构：
[1] Univ Illinois, Chicago, IL 60607 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 366卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1447 / 1448
页数：2
相关论文
共 50 条
  • [21] Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates
    Simkins, Jacques
    Abbo, Lilian Margarita
    Camargo, Jose Fernando
    Rosa, Rossana
    Morris, Michele Ileana
    TRANSPLANTATION, 2017, 101 (06) : 1468 - 1472
  • [22] Three Months of Weekly Rifapentine Plus Isoniazid for Latent Tuberculosis Treatment in Solid Organ Transplant Candidates.
    Knoll, B.
    Nog, R.
    Wu, Y.
    Dhand, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 730 - 730
  • [23] Update of the Recommendations for the Use of Once-Weekly Isoniazid-Rifapentine Regimen to Latent Mycobaterium tuberculosis Infection
    Alabaz, Derya
    JOURNAL OF PEDIATRIC INFECTION, 2019, 13 (01): : E58 - E61
  • [24] High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus
    Jarrett, Ryan T.
    van der Heijden, Yuri
    Shotwell, Matthew S.
    Chihota, Violet
    Marzinke, Mark A.
    Chaisson, Richard E.
    Dooley, Kelly E.
    Churchyard, Gavin J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (02)
  • [25] Eradicating latent tuberculosis: use of interferon gamma release assay and isoniazid/rifapentine in people living with HIV/AIDS
    Monteiro, Mariana Amelia
    Apoliano, Carlos Fernando
    Martins, Jose Eduardo Rodrigues
    Sunada, Noemia Orii
    Folgosi, Victor angelo
    Nascimento, Najara Ataide de Lima
    Chimara, Erica
    Veiga, Ana Paula Rocha
    Pereira, Luisa de Oliveira
    Andrade, Luisa Caracik de Camargo
    Tiberto, Larissa
    Ferreira, Mauricio Domingues
    Fonseca, Luiz Augusto Marcondes
    Duarte, Alberto Jose da Silva
    Arakaki-Sanchez, Denise
    Hong, Marisa Ailin
    Casseb, Jorge
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2025, 67
  • [26] COMPARISON OF DIRECTLY OBSERVED ISONIAZID-RIFAPENTINE WITH SELF ADMINISTERED ISONIAZID AND RIFAMPIN REGIMENS FOR LATENT TUBERCULOSIS INFECTION-A PUBLIC HEALTH PERSPECTIVE
    Yamin, A.
    Kempker, R.
    Bornstein, E.
    Hensen, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (02) : 472 - 472
  • [27] Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
    Lai, Wendy A. A.
    Brethour, Kaitlyn
    D'Silva, Olivia
    Chaisson, Richard E. E.
    Zwerling, Alice A. A.
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [28] Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
    Wendy A. Lai
    Kaitlyn Brethour
    Olivia D’Silva
    Richard E. Chaisson
    Alice A. Zwerling
    BMC Public Health, 22
  • [29] Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?
    Rosenthal, Ian M.
    Zhang, Ming
    Almeida, Deepak
    Grosset, Jacques H.
    Nuermberger, Eric L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (09) : 989 - 993
  • [30] Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine
    Weiner, M
    Burman, W
    Vernon, A
    Benator, D
    Peloquin, CA
    Khan, A
    Weis, S
    King, B
    Shah, N
    Hodge, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (10) : 1341 - 1347
12345